Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

The US Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular ...

is a disease that gradually damages the macula, the part of your eye’s retina responsible for sharp, central vision. As it worsens, people find it increasingly difficult to see things directly ...

UAB ophthalmology professor awarded prestigious award for vision research in diabetic retinopathy and macular degeneration ...

Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.

for the treatment of Macular Telangiectasia type 2 (MacTel). MacTel is a neurodegenerative disease of the retina in adults that causes progressive and irreversible vision loss, significantly ...

NY Retina, a newly launched ophthalmology practice, is set to open March 20 in a newly purchased medical office building in ...